Insider Trading activities at Roivant Sciences Ltd. (ROIV)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Roivant Sciences Ltd. (ROIV) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Roivant Sciences Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1635088.

Total stock buying since 2022: $20,204,912.
Total stock sales since 2022: $1,689,572,972.
Total stock option exercises since 2022: $206,719,671.


 1   2 
14 insiders reported insider trading activities at Roivant Sciences Ltd. (ROIV):
Insider trading activities of Qvt Financial Lp
Insider trading activities of Manchester Keith S
Insider trading activities of Sukhatme Mayukh
Insider trading activities of Viking Global Opportunities Parent Gp Llc
Insider trading activities of Sb Investment Advisers (uk) Ltd
Insider trading activities of Viking Long Fund Gp Llc
Insider trading activities of Gold Daniel Allen
Insider trading activities of Gline Matthew
Insider trading activities of Oren Dan
Insider trading activities of Kumar Rakhi
Insider trading activities of Venker Eric
Insider trading activities of Sumitomo Pharma Co., Ltd.
Insider trading activities of Ramaswamy Vivek
Insider trading activities of Pulik Richard

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Roivant Sciences Ltd. (ROIV).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 3,315 $49,957 26,847,136 $485,696,151 19,159,460 $178,010,805
2024 0 $0 9,152,395 $107,456,064 4,129,194 $11,586,705
2023 0 $0 98,491,997 $998,482,427 5,797,183 $17,122,161
2022 4,040,285 $20,154,955 20,599,995 $97,938,330 0 $0

Table 2. Monthly summary of insider trading at Roivant Sciences Ltd. (ROIV).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-12 0 $0 10,154,418 $227,583,759 11,505,040 $132,997,501
2025-11 0 $0 5,954,603 $120,813,811 200,000 $770,000
2025-10 0 $0 1,642,209 $27,296,649 1,642,209 $21,866,293
2025-09 3,315 $49,957 3,486,749 $47,983,148 1,562,374 $6,015,139
2025-08 0 $0 100,000 $1,172,000 100,000 $385,000
2025-07 0 $0 100,000 $1,152,000 100,000 $385,000
2025-06 0 $0 2,242,273 $25,384,736 1,485,026 $5,717,350
2025-05 0 $0 998,959 $11,224,809 100,000 $385,000
2025-04 0 $0 100,000 $1,022,000 100,000 $385,000
2025-03 0 $0 750,000 $8,190,724 1,002,311 $3,858,897
2025-02 0 $0 1,217,925 $12,744,515 1,262,500 $4,860,625
2025-01 0 $0 100,000 $1,128,000 100,000 $385,000
2024-12 0 $0 767,188 $9,113,299 912,584 $3,513,448
2024-11 0 $0 100,000 $1,132,000 100,000 $385,000
2024-10 0 $0 100,000 $1,165,000 100,000 $385,000
2024-09 0 $0 8,088,257 $94,987,071 1,800,000 $6,930,000
2024-03 0 $0 0 $0 1,119,660 $0
2024-02 0 $0 96,950 $1,058,694 96,950 $373,257
2023-12 0 $0 0 $0 385,058 $0
2023-10 0 $0 1,200,000 $12,520,988 1,200,000 $4,619,998
2023-09 0 $0 37,697,612 $446,807,955 966,723 $3,351,474
2023-08 0 $0 186,251 $2,218,099 307,618 $727,628
2023-07 0 $0 618,007 $6,965,208 850,425 $2,380,992
2023-06 0 $0 41,459,755 $390,804,713 343,478 $1,378,133

Table 3. Detailed insider trading at Roivant Sciences Ltd. (ROIV)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-12-17 Gold Daniel Allen Sale 777,332 23.08 17,940,822
2025-12-17 Sukhatme Mayukh (President & CIO) Sale 26,831 23.09 619,527
2025-12-17 Sukhatme Mayukh (President & CIO) Option Ex 59,513 12.68 754,624
2025-12-17 Qvt Financial Lp Sale 777,332 23.08 17,940,822
2025-12-17 Manchester Keith S Sale 777,332 23.08 17,940,822
2025-12-16 Gold Daniel Allen Sale 917,282 23.00 21,102,072
2025-12-16 Qvt Financial Lp Sale 917,282 23.00 21,102,072
2025-12-16 Manchester Keith S Sale 917,282 23.00 21,102,072
2025-12-15 Gline Matthew (CEO) Sale 1,740,000 21.68 37,723,200
2025-12-15 Gline Matthew (CEO) Option Ex 3,870,659 9.81 37,959,552
2025-12-15 Ramaswamy Vivek (10% Owner) Sale 353,745 22.05 7,800,077
2025-12-15 Ramaswamy Vivek (10% Owner) Option Ex 832,453 12.68 10,555,504
2025-12-12 Ramaswamy Vivek (10% Owner) Sale 1,975,858 21.96 43,389,841
2025-12-12 Ramaswamy Vivek (10% Owner) Option Ex 4,672,724 12.68 59,250,140
2025-12-11 Ramaswamy Vivek (10% Owner) Sale 774,142 21.64 16,752,432
2025-12-11 Ramaswamy Vivek (10% Owner) Option Ex 1,869,691 12.68 23,707,681
2025-12-09 Venker Eric (President & Immunovant CEO) Sale 200,000 20.85 4,170,000
2025-12-09 Venker Eric (President & Immunovant CEO) Option Ex 200,000 3.85 770,000
2025-11-19 Gold Daniel Allen Sale 1,300,000 20.21 26,276,900
2025-11-19 Qvt Financial Lp Sale 1,300,000 20.21 26,276,900
2025-11-19 Manchester Keith S Sale 1,300,000 20.21 26,276,900
2025-11-17 Ramaswamy Vivek (10% Owner) Sale 539,650 20.51 11,068,221
2025-11-14 Ramaswamy Vivek (10% Owner) Sale 1,027,670 20.33 20,892,531
2025-11-13 Ramaswamy Vivek (10% Owner) Sale 287,283 20.81 5,978,359
2025-11-07 Venker Eric (President & Immunovant CEO) Sale 200,000 20.22 4,044,000
2025-11-07 Venker Eric (President & Immunovant CEO) Option Ex 200,000 3.85 770,000
2025-10-17 Venker Eric (President & Immunovant CEO) Sale 118,418 17.06 2,020,211
2025-10-17 Venker Eric (President & Immunovant CEO) Option Ex 118,418 15.85 1,876,925
2025-10-16 Venker Eric (President & Immunovant CEO) Sale 318,282 17.05 5,426,708
2025-10-16 Venker Eric (President & Immunovant CEO) Option Ex 318,282 15.85 5,044,769
2025-10-15 Venker Eric (President & Immunovant CEO) Sale 414,683 16.93 7,020,583
2025-10-15 Venker Eric (President & Immunovant CEO) Option Ex 414,683 15.85 6,572,725
2025-10-13 Venker Eric (President & Immunovant CEO) Sale 20,727 16.25 336,813
2025-10-13 Venker Eric (President & Immunovant CEO) Option Ex 20,727 15.85 328,522
2025-10-09 Venker Eric (President & Immunovant CEO) Sale 104,940 16.30 1,710,522
2025-10-09 Venker Eric (President & Immunovant CEO) Option Ex 104,940 15.85 1,663,299
2025-10-08 Venker Eric (President & Immunovant CEO) Sale 138,602 16.20 2,245,352
2025-10-08 Venker Eric (President & Immunovant CEO) Option Ex 138,602 11.65 1,614,713
2025-10-07 Venker Eric (President & Immunovant CEO) Sale 355,161 16.15 5,735,850
2025-10-07 Venker Eric (President & Immunovant CEO) Option Ex 355,161 9.05 3,214,207
2025-10-06 Venker Eric (President & Immunovant CEO) Sale 171,396 16.34 2,800,610
2025-10-06 Venker Eric (President & Immunovant CEO) Option Ex 171,396 9.05 1,551,133
2025-09-23 Venker Eric (President & Immunovant CEO) Sale 611,000 14.83 9,061,130
2025-09-22 Venker Eric (President & Immunovant CEO) Sale 416,182 15.00 6,242,730
2025-09-22 Venker Eric (President & Immunovant CEO) Option Ex 562,374 3.85 2,165,139
2025-09-19 Venker Eric (President & Immunovant CEO) Sale 683,818 14.95 10,223,079
2025-09-19 Venker Eric (President & Immunovant CEO) Option Ex 1,000,000 3.85 3,850,000
2025-09-18 Gline Matthew (CEO) Buy 3,315 15.07 49,957
2025-09-05 Ramaswamy Vivek (10% Owner) Sale 385,816 12.96 5,000,175
2025-09-04 Ramaswamy Vivek (10% Owner) Sale 194,933 12.92 2,518,534
2025-09-03 Ramaswamy Vivek (10% Owner) Sale 1,195,000 12.50 14,937,500
2025-08-20 Venker Eric (President & Immunovant CEO) Sale 100,000 11.72 1,172,000
2025-08-20 Venker Eric (President & Immunovant CEO) Option Ex 100,000 3.85 385,000
2025-07-21 Venker Eric (President & Immunovant CEO) Sale 100,000 11.52 1,152,000
2025-07-21 Venker Eric (President & Immunovant CEO) Option Ex 100,000 3.85 385,000
2025-06-20 Venker Eric (President & COO) Sale 100,000 11.45 1,145,000
2025-06-20 Venker Eric (President & COO) Option Ex 100,000 3.85 385,000
2025-06-20 Ramaswamy Vivek (10% Owner) Sale 577,007 11.46 6,612,500
2025-06-18 Ramaswamy Vivek (10% Owner) Sale 565,266 11.45 6,472,295
2025-06-03 Venker Eric (President & COO) Sale 566,278 11.22 6,353,639
2025-06-03 Venker Eric (President & COO) Option Ex 785,026 3.85 3,022,350
2025-06-02 Venker Eric (President & COO) Sale 433,722 11.07 4,801,302
2025-06-02 Venker Eric (President & COO) Option Ex 600,000 3.85 2,310,000
2025-05-20 Venker Eric (President & COO) Sale 100,000 10.95 1,095,000
2025-05-20 Venker Eric (President & COO) Option Ex 100,000 3.85 385,000
2025-05-07 Ramaswamy Vivek Sale 625,000 11.18 6,987,500
2025-05-06 Ramaswamy Vivek Sale 273,959 11.47 3,142,309
2025-04-21 Venker Eric (President & COO) Sale 100,000 10.22 1,022,000
2025-04-21 Venker Eric (President & COO) Option Ex 100,000 3.85 385,000
2025-03-24 Venker Eric (President & COO) Sale 434,478 10.82 4,701,051
2025-03-24 Venker Eric (President & COO) Option Ex 602,311 3.85 2,318,897
2025-03-20 Venker Eric (President & COO) Sale 315,522 11.06 3,489,673
2025-03-20 Venker Eric (President & COO) Option Ex 400,000 3.85 1,540,000
2025-02-20 Venker Eric (President & COO) Sale 100,000 10.65 1,065,000
2025-02-20 Venker Eric (President & COO) Option Ex 100,000 3.85 385,000
2025-02-13 Kumar Rakhi (Chief Accounting Officer) Sale 455,000 10.43 4,745,650
2025-02-13 Kumar Rakhi (Chief Accounting Officer) Option Ex 375,000 3.85 1,443,750
2025-02-13 Venker Eric (President & COO) Sale 218,041 10.42 2,271,987
2025-02-13 Venker Eric (President & COO) Option Ex 300,000 3.85 1,155,000
2025-02-12 Venker Eric (President & COO) Sale 217,384 10.53 2,289,053
2025-02-12 Venker Eric (President & COO) Option Ex 300,000 3.85 1,155,000
2025-01-21 Venker Eric (President & COO) Sale 100,000 11.28 1,128,000
2025-01-21 Venker Eric (President & COO) Option Ex 100,000 3.85 385,000
2024-12-30 Venker Eric (President & COO) Sale 177,704 11.54 2,050,704
2024-12-30 Venker Eric (President & COO) Option Ex 250,000 3.85 962,500
2024-12-27 Venker Eric (President & COO) Sale 176,900 11.82 2,090,958
2024-12-27 Venker Eric (President & COO) Option Ex 250,000 3.85 962,500
2024-12-18 Sukhatme Mayukh (Pres&Chief Investment Officer) Sale 412,584 12.05 4,971,637
2024-12-18 Sukhatme Mayukh (Pres&Chief Investment Officer) Option Ex 412,584 3.85 1,588,448
2024-11-20 Venker Eric (President & COO) Sale 100,000 11.32 1,132,000
2024-11-20 Venker Eric (President & COO) Option Ex 100,000 3.85 385,000
2024-10-21 Venker Eric (President & COO) Sale 100,000 11.65 1,165,000
2024-10-21 Venker Eric (President & COO) Option Ex 100,000 3.85 385,000
2024-09-26 Gold Daniel Allen Sale 876,000 11.82 10,354,320
2024-09-26 Qvt Financial Lp Sale 876,000 11.82 10,354,320
2024-09-25 Gold Daniel Allen Sale 1,407,144 11.77 16,557,863
2024-09-25 Qvt Financial Lp Sale 50,000 11.77 588,500
2024-09-25 Manchester Keith S Sale 134,948 11.77 1,587,663
2024-09-24 Gold Daniel Allen Sale 2,142,856 11.62 24,910,701
2024-09-24 Manchester Keith S Sale 368,052 11.62 4,278,604
2024-09-23 Kumar Rakhi (Chief Accounting Officer) Sale 250,000 11.89 2,972,500
2024-09-23 Kumar Rakhi (Chief Accounting Officer) Option Ex 250,000 3.85 962,500
2024-09-23 Gline Matthew (CEO) Sale 1,983,257 11.79 23,382,600
2024-09-23 Gline Matthew (CEO) Option Ex 1,550,000 3.85 5,967,500
2024-03-30 Gline Matthew (CEO) Option Ex 390,579 .00 0
2024-03-30 Sukhatme Mayukh (Pres&Chief Investment Officer) Option Ex 729,081 .00 0
2024-02-09 Venker Eric (President & COO) Sale 96,950 10.92 1,058,694
2024-02-09 Venker Eric (President & COO) Option Ex 96,950 3.85 373,257
2023-12-27 Kumar Rakhi (Chief Accounting Officer) Option Ex 13 .00 0
2023-12-27 Gline Matthew (CEO) Option Ex 38,453 .00 0
2023-12-27 Sukhatme Mayukh (Pres&Chief Investment Officer) Option Ex 71,365 .00 0
2023-12-27 Ramaswamy Vivek Option Ex 275,227 .00 0
2023-10-05 Venker Eric (Chief Operating Officer) Sale 153,027 10.11 1,547,102
2023-10-04 Venker Eric (Chief Operating Officer) Option Ex 153,027 3.85 589,153
2023-10-03 Venker Eric (Chief Operating Officer) Sale 606,221 10.25 6,213,765
2023-10-03 Venker Eric (Chief Operating Officer) Option Ex 606,221 3.85 2,333,950
2023-10-02 Venker Eric (Chief Operating Officer) Sale 440,752 10.80 4,760,121
2023-10-02 Venker Eric (Chief Operating Officer) Option Ex 440,752 3.85 1,696,895
2023-09-28 Gold Daniel Allen (Director) Sale 10,000,000 11.55 115,500,000
2023-09-28 Sb Investment Advisers (uk) Ltd Sale 10,000,000 12.60 126,000,000
2023-09-28 Qvt Financial Lp Sale 10,000,000 11.55 115,500,000
2023-09-28 Manchester Keith S Sale 6,896,144 11.55 79,650,463
2023-09-27 Kumar Rakhi (Chief Accounting Officer) Option Ex 169 .00 0
2023-09-27 Venker Eric (President & COO) Sale 500,000 13.02 6,510,000
2023-09-27 Venker Eric (President & COO) Option Ex 500,000 3.85 1,925,000
2023-09-27 Gline Matthew (CEO) Option Ex 17,762 .00 0
2023-09-27 Sukhatme Mayukh (Pres&Chief Investment Officer) Option Ex 27,790 .00 0
2023-09-27 Ramaswamy Vivek Option Ex 119,534 .00 0
2023-09-08 Kumar Rakhi (Chief Accounting Officer) Sale 99,350 12.18 1,210,083
2023-09-08 Kumar Rakhi (Chief Accounting Officer) Option Ex 99,350 6.48 643,788
2023-09-08 Venker Eric (Chief Operating Officer) Sale 106,430 12.19 1,297,381
2023-09-08 Venker Eric (Chief Operating Officer) Option Ex 106,430 3.85 409,755
2023-09-06 Venker Eric (Chief Operating Officer) Sale 5,926 11.85 70,223
2023-09-06 Venker Eric (Chief Operating Officer) Option Ex 5,926 3.85 22,815
2023-09-05 Kumar Rakhi (Chief Accounting Officer) Sale 1,724 12.00 20,688
2023-09-05 Kumar Rakhi (Chief Accounting Officer) Option Ex 1,724 6.48 11,171
2023-09-05 Venker Eric (Chief Operating Officer) Sale 73,275 11.92 873,438
2023-09-05 Venker Eric (Chief Operating Officer) Option Ex 73,275 3.85 282,108
2023-09-01 Venker Eric (Chief Operating Officer) Sale 14,763 11.90 175,679
2023-09-01 Venker Eric (Chief Operating Officer) Option Ex 14,763 3.85 56,837
2023-08-27 Gline Matthew (CEO) Option Ex 12,088 .00 0
2023-08-27 Sukhatme Mayukh (Pres&Chief Investment Officer) Option Ex 22,565 .00 0
2023-08-27 Ramaswamy Vivek Option Ex 86,714 .00 0
2023-08-14 Venker Eric (Chief Operating Officer) Sale 59,811 11.89 711,152
2023-08-14 Venker Eric (Chief Operating Officer) Option Ex 59,811 3.85 230,272
2023-08-03 Kumar Rakhi (Chief Accounting Officer) Sale 3,681 12.00 44,172
2023-08-03 Kumar Rakhi (Chief Accounting Officer) Option Ex 3,681 6.48 23,852
2023-08-03 Venker Eric (Chief Operating Officer) Sale 44,629 11.93 532,423
2023-08-03 Venker Eric (Chief Operating Officer) Option Ex 44,629 3.85 171,821
2023-08-02 Venker Eric (Chief Operating Officer) Sale 16,397 11.86 194,468
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of ROIV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Roivant Sciences Ltd. (symbol ROIV, CIK number 1635088) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.